Milestone Therapeutics develops investigational therapies for cardiovascular conditions, including etripamil for paroxysmal supraventricular tachycardia (PSVT).

Case Studies

Showing 1 Success Stories about Software and Services used by Milestone Therapeutics

Milestone Therapeutics amplifies pivotal cardiology trial data with JPA Health

No matching case studies